INTERNATIONAL CONFERENCE ON PHARMACOLOGY AND PHARMA NETWORK

September 26-28, 2019 | USA

Pharma Houston 2019 will provide a platform for researchers, practitioners, and educators to exchange practical experiences, research evidence, and innovative ideas on issues related to pharmacology and pharmaceutical sciences. pharmacology & regulatory affairs that cover drug interactions, pharmacologic concerns on both experimental and clinical levels, clinical toxicology, research on the toxicological and pharmacological effects of environmental contaminants, pharmacokinetics, pharmacodynamics, collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.

Spotlight

Responses from 100 patient services executives in the US on current and anticipated activities and investments in patient services across seven therapeutic areas. Patient services are delivering value with a significant increase in focus and investment expected over the next two years. Although only of the US respondents rate their 52% patient-centric capabilities as strong today. 84% of US companies are raising their investment in patient-centric capabilities over the next 18 months. US companies primarily make patients aware of their services through healthcare professionals, however, less than 1 in 5 patients are aware of the services. Focus conversations on the outcomes achieved by the solutions (products + services) you o¬er. When healthcare professionals see the bundled solution as integral to achieving better outcomes, they will be much more inclined to discuss the solution with the patient.


OTHER PAST CONFERENCES

13th Global Drug Delivery And Formulation Summit

June 27-29, 2022 | USA

Innovative solutions to the greatest challenges in pharmaceutical development

Medicinal Chemistry and Drug Design

July 4-5, 2022 | UK

Chemistry Conferences welcome chemical professionals, researchers, professors, scientific communities, delegates, students, business professionals and executives from all over the world to attend the “22nd World Congress on Medicinal Chemistry and Drug Design” which is to be held during July 04-05, 2022 Aberdeen, UK.

3rd European Congress on Pharmaceutical Science And Research

August 15-16, 2022 | Singapore

PHARMACEUTICAL SCIENCE 2022 welcomes attendees, presenters, and exhibitors from all over the world to Singapore. We are delighted to invite you all to attend and register for the “3rd European Congress on Pharmaceutical Science & Research” which is going to be held during August 15-16, 2022 in Singapore.

IDN & Bio/Pharma Partnering Summit

August 16-17, 2022 | USA

A think-tank for industry pioneers, showcasing novel case studies and innovative partnership models that deliver enhanced value, manage costs and improve quality

Spotlight

Responses from 100 patient services executives in the US on current and anticipated activities and investments in patient services across seven therapeutic areas. Patient services are delivering value with a significant increase in focus and investment expected over the next two years. Although only of the US respondents rate their 52% patient-centric capabilities as strong today. 84% of US companies are raising their investment in patient-centric capabilities over the next 18 months. US companies primarily make patients aware of their services through healthcare professionals, however, less than 1 in 5 patients are aware of the services. Focus conversations on the outcomes achieved by the solutions (products + services) you o¬er. When healthcare professionals see the bundled solution as integral to achieving better outcomes, they will be much more inclined to discuss the solution with the patient.

resources